SCHEMBL73930

SCHEMBL73930

Cc1ccccc1N(c1ccccc1)c1ccc(-c2ccc(N(c3ccccc3)c3ccccc3C)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.40
ALDH1A1 P00352 3/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
KDM4E B2RXH2 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
MAPT P10636 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
TSHR P16473 1/20 0.36
ACHE P22303 1/20 0.36
APP P05067 2/20 0.36
HDAC6 Q9UBN7 1/20 0.34
MEN1 O00255 1/20 0.34
CRHBP P24387 1/20 0.34
KMT2A Q03164 1/20 0.34
ATM Q13315 1/20 0.34
CRHR2 Q13324 1/20 0.34
TLR9 Q9NR96 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13929897 1.00 CYP3A4 (0.40) CYP3A4ALDH1A1L3MBTL1KDM4ECYP1A2
SCHEMBL31390117 0.98 CYP3A4 (0.43) CYP3A4ALDH1A1L3MBTL1KDM4ECYP1A2
SCHEMBL19102572 0.98 CYP3A4 (0.43) CYP3A4ALDH1A1L3MBTL1KDM4ECYP1A2
SCHEMBL2887338 0.98 ALDH1A1 (0.39) CYP3A4ALDH1A1L3MBTL1KDM4ECYP1A2
SCHEMBL16324036 0.98 CYP3A4 (0.43) CYP3A4ALDH1A1L3MBTL1KDM4ECYP1A2
SCHEMBL17368989 0.96 ALDH1A1 (0.38) CYP3A4ALDH1A1L3MBTL1KDM4ECYP1A2
SCHEMBL19393440 0.96 ALDH1A1 (0.38) CYP3A4ALDH1A1L3MBTL1KDM4ECYP1A2
SCHEMBL10053544 0.94 HSD17B1 (0.39) CYP3A4ALDH1A1L3MBTL1KDM4ECYP1A2
SCHEMBL312725 0.94 CYP3A4 (0.36) CYP3A4ALDH1A1L3MBTL1KDM4ECYP1A2
SCHEMBL14047707 0.94 HSD17B1 (0.39) CYP3A4ALDH1A1L3MBTL1KDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 358 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150037732-A1 METHOD FOR MANUFACTURING PHOTORECEPTOR LAYERS XEROX CORPORATION (US) 2015-02-05 US claimed
US-7642028-B2 surface layers are a polymeric composition including a resin and a cyclic polymers such as polyethylene terephthalate, acrylic acid-ethylene copolymer, styrene-co-maleic anhydride copolymer; polyhexamethylene adipamide etc. and cyclic poly(bisphenol A carbonate), cyclic poly(bisphenol C carbonate) etc. XEROX CORPORATION (US) 2010-01-05 US claimed
US-7267917-B2 Photoreceptor charge transport layer composition XEROX CORPORATION (US) 2007-09-11 US claimed
US-20060210894-A1 Imaging members XEROX CORPORATION 2006-09-21 US claimed
US-20060063080-A1 Photoreceptor charge transport layer composition XEROX CORPORATION (US) 2006-03-23 US claimed
US-6532098-B1 Sandwiched between two electrically conductive substrates at least one of which is transparent; benzidine or phenylenediamine compounds, acryloyl-modified polyalkylene oxide; viologen compound NIPPON MITSUBISHI OIL CORPORATION (JP) 2003-03-11 US claimed
US-6180301-B1 DISPERSION QUALITY; XEROGRAPHIC CHARACTERISTICS XEROX CORPORATION 2001-01-30 US claimed
EP-0486038-B1 Electrophotographic photoreceptor IDEMITSU KOSAN CO (JP) 1996-10-16 EP claimed
US-5534376-A PHOTOSENSITIVE TO NEAR INFRARED RADIATION; XEROGRAPHY XEROX CORPORATION (US) 1996-07-09 US claimed
US-5213924-A Copolymers, improved mechanical strength, hardness IDEMITSU KOSAN CO. LTD. (JP) 1993-05-25 US claimed
US-4371600-A Release overcoat for photoresponsive device XEROX CORPORATION (US) 1983-02-01 US claimed
US-4314012-A Photoconductive reflex exposure member XEROX CORPORATION (US) 1982-02-02 US claimed
US-4047949-A Composite layered imaging member for electrophotography XEROX CORPORATION (US) 1977-09-13 US claimed
JP-62242951-A None JP disclosed
US-20240166592-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMINTS, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2024-05-23 US disclosed
US-20230380275-A1 PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND FUJIFLM CORPORATION (JP) 2023-11-23 US disclosed
US-4346158-A Imaging system with a diamine charge transport material in a polycarbonate resin XEROX CORPORATION (US) 1982-08-24 US disclosed
US-4314012-A Photoconductive reflex exposure member XEROX CORPORATION (US) 1982-02-02 US disclosed
US-4265990-A Imaging system with a diamine charge transport material in a polycarbonate resin XEROX CORPORATION (US) 1981-05-05 US disclosed
US-4123269-A Electrostatographic photosensitive device comprising hole injecting and hole transport layers XEROX CORPORATION (US) 1978-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240166592-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMINTS, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE LEF1, L1CAM, RFT1 CYP3A4 2065/4885ALDH1A1 161/4885L3MBTL1 16/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.